• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

522 Postmarket Surveillance Studies

  • Print
  • Share
  • E-mail

522 Postmarket Surveillance Studies

  • In May 2008, the oversight responsibility of the 522 Postmarket Surveillance Studies Program was transferred to the Division of Epidemiology (DEPI) of the Office of Surveillance and Biometrics (OSB)/Center for Devices and Radiological Health (CDRH). DEPI continues to build the 522 program.
  • The 522 Postmarket Surveillance Studies Program encompasses design, tracking, oversight, and review responsibilities for studies mandated under section 522 of the Federal Food, Drug and Cosmetic Act. The program helps ensure that well-designed 522 postmarket surveillance (PS) studies are conducted effectively and efficiently and in the least burdensome manner.
  • CDRH has established an automated internal tracking system that efficiently identifies the reporting status of active 522 PS studies based on study timelines incorporated in study protocols and agreed upon by the CDRH and applicants. This system represents CDRH's effort to ensure that all 522 PS commitments are fulfilled in a timely manner.
  • In addition, CDRH launched this publicly available webpage to keep all stakeholders informed of the progress of each 522 PS study. The webpage displays general information regarding each study, as well as the overall study status (based on protocol-driven timelines and adequacy of the data) and the applicant's reporting status for each submission due.


Contact Information

Nathan S. Ivey, PhD
Senior Scientific Project Manager, 522 Postmarket Surveillance (PS) Studies Program
Food and Drug Administration
10903 New Hampshire Ave
Silver Spring, MD 20993-0002

Phone: (301) 796-7033
Fax: (301) 847-8140
Show All Studies
Suggest Enhancement / Report Issue  Export to ExcelExport to Excel
Most Recent
Plan Version
Study Status
PS110011 Metal Ion Levels 08/17/2012 Transit. Adolescent B (as adults) : 18-21 yrs, Adult: >21 Consolidated

Metal Ion Levels Schedule

Report Schedule
Date Due
FDA Receipt
Applicant's Reporting Status
Report and Ext Request 08/14/2012 08/14/2012 On Time
6 Month Report 08/20/2012 08/20/2012 On Time
12 Month Report 03/29/2013 02/13/2013 On Time
18 month report 08/13/2013 08/14/2013 Overdue/Received
2 yr report 02/12/2014 02/19/2014 Overdue/Received

Show All Studies